Prakriti Gaba1, J Martijn Bos2, Bryan C Cannon3, Yong-Mei Cha4, Paul A Friedman4, Samuel J Asirvatham4, Michael J Ackerman5. 1. Mayo Medical School, Mayo Clinic, Rochester, Minnesota. 2. Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota; Department of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. 3. Department of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. 4. Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota. 5. Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota; Department of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota. Electronic address: ackerman.michael@mayo.edu.
Abstract
BACKGROUND: Primary treatment of long QT syndrome (LQTS) currently consists of beta-blocker therapy, although an implantable cardioverter-defibrillator (ICD) is considered for high-risk patients. However, both overdiagnosis and overtreatment must be avoided because their sequelae can be significant. OBJECTIVE: The purpose of this study was to evaluate the prevalence and details of ICD explants in a cohort of patients from a tertiary genetic heart rhythm clinic for a previously rendered diagnosis of LQTS. METHODS: Overall, 1227 consecutive patients were included in the study. All patients had been referred to the Mayo Clinic for evaluation of possible LQTS and subsequently were either diagnosed with LQTS or dismissed as normal. Further stratification of patients was conducted to assess how many patients had an ICD and how many had a subsequent ICD explant. RESULTS: In total, 170 patients (14%) had an ICD, including 157 of 670 patients (23%) with confirmed LQTS and 13 of 557 patients (2%) who did not have LQTS. Among these, 12 of 1227 (1%) had the ICD removed: 7 of 157 LQTS patients (4.5%) compared to 5 of 14 non-LQTS patients (36%). Before explant, 5 of 12 patients (42%) experienced inappropriate shocks, ranging from 2 to as many as 54 shocks. In addition, 4 had a device-related infection, and 9 had device malfunction (including lead dysfunction or fracture). None of these patients had a breakthrough cardiac event since removal of their ICD during 5.5 ± 3.5 years of follow-up. CONCLUSION: Implications of overdiagnosis and overtreatment are profound because unnecessary ICD placement can be associated with infection, malfunction, inappropriate shocks, and subsequent anxiety.
BACKGROUND: Primary treatment of long QT syndrome (LQTS) currently consists of beta-blocker therapy, although an implantable cardioverter-defibrillator (ICD) is considered for high-risk patients. However, both overdiagnosis and overtreatment must be avoided because their sequelae can be significant. OBJECTIVE: The purpose of this study was to evaluate the prevalence and details of ICD explants in a cohort of patients from a tertiary genetic heart rhythm clinic for a previously rendered diagnosis of LQTS. METHODS: Overall, 1227 consecutive patients were included in the study. All patients had been referred to the Mayo Clinic for evaluation of possible LQTS and subsequently were either diagnosed with LQTS or dismissed as normal. Further stratification of patients was conducted to assess how many patients had an ICD and how many had a subsequent ICD explant. RESULTS: In total, 170 patients (14%) had an ICD, including 157 of 670 patients (23%) with confirmed LQTS and 13 of 557 patients (2%) who did not have LQTS. Among these, 12 of 1227 (1%) had the ICD removed: 7 of 157 LQTS patients (4.5%) compared to 5 of 14 non-LQTS patients (36%). Before explant, 5 of 12 patients (42%) experienced inappropriate shocks, ranging from 2 to as many as 54 shocks. In addition, 4 had a device-related infection, and 9 had device malfunction (including lead dysfunction or fracture). None of these patients had a breakthrough cardiac event since removal of their ICD during 5.5 ± 3.5 years of follow-up. CONCLUSION: Implications of overdiagnosis and overtreatment are profound because unnecessary ICD placement can be associated with infection, malfunction, inappropriate shocks, and subsequent anxiety.
Authors: Kyung Jin Ahn; Mi Kyoung Song; Sang Yun Lee; Ja Kyoung Yoon; Gi Beom Kim; Seil Oh; Eun Jung Bae Journal: Korean Circ J Date: 2022-10 Impact factor: 3.101
Authors: Rachel L Draelos; Jordan E Ezekian; Farica Zhuang; Mary E Moya-Mendez; Zhushan Zhang; Michael B Rosamilia; Perathu K R Manivannan; Ricardo Henao; Andrew P Landstrom Journal: Circ Arrhythm Electrophysiol Date: 2022-03-31
Authors: Melissa A Kelly; Colleen Caleshu; Ana Morales; Jillian Buchan; Zena Wolf; Steven M Harrison; Stuart Cook; Mitchell W Dillon; John Garcia; Eden Haverfield; Jan D H Jongbloed; Daniela Macaya; Arjun Manrai; Kate Orland; Gabriele Richard; Katherine Spoonamore; Matthew Thomas; Kate Thomson; Lisa M Vincent; Roddy Walsh; Hugh Watkins; Nicola Whiffin; Jodie Ingles; J Peter van Tintelen; Christopher Semsarian; James S Ware; Ray Hershberger; Birgit Funke Journal: Genet Med Date: 2018-01-04 Impact factor: 8.822
Authors: Makoto Ono; Don E Burgess; Elizabeth A Schroder; Claude S Elayi; Corey L Anderson; Craig T January; Bin Sun; Kalyan Immadisetty; Peter M Kekenes-Huskey; Brian P Delisle Journal: Biomolecules Date: 2020-08-04